Evidence map›Paper›PMID 40496052›Full record

ArticleNutrition research and practice2025

The combination of water extracts of

Ja Yeon Park, Woo Yong Park, Beomsu Lee, Gahee Song, Yunu Jung, Hyun Jeong Kwak, Kwang Seok Ahn, Jinbong Park, Jae-Young Um

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrition research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ja Yeon ParkDepartment of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0009-0003-2107-5087
Woo Yong ParkDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0003-4188-3826
Beomsu LeeDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0009-0009-3705-2617
Gahee SongDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0002-3754-8294
Yunu JungDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0002-2279-7896
Hyun Jeong KwakDepartment of Bio and Fermentation Convergence Technology, Kookmin University, Seoul 02707, Korea.ORCID https://orcid.org/0000-0001-7070-6066
Kwang Seok AhnDepartment of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0002-2882-0612
Jinbong ParkDepartment of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0002-5984-5855
Jae-Young UmDepartment of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea.ORCID https://orcid.org/0000-0002-0568-9738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesThe traditional medicinal use of MATERIALS/

methodsWe established BPH mimicking

resultsTP treatments induced several pathological symptoms of BPH, such as enlarged prostate tissue, increased dihydrotestosterone serum level, and thickened epithelial thickness in TP-induced BPH rats. CR and SF treatment significantly alleviated these signs. In addition, CR and SF reduced the protein expression of BPH-related factors and cell proliferation. Similar patterns of changes were also seen

conclusionThese results showed that CR and SF alleviated BPH by inhibiting cell proliferation. Also, unlike Fi, sperm loss did not occur by CR and SF co-treatment. Based on these results, we suggested that CR and SF are new substitutes for BPH treatment.

Indexed as

androgen receptorcurcumafinasterideProstatic hyperplasiasyzygium

Identifiers

PMID40496052
PMCPMC12148630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.